Page last updated: 2024-08-17

nadp and Hypertension, Malignant

nadp has been researched along with Hypertension, Malignant in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akimoto, K; Ishikawa, Y; Ishimura, K; Matsuoka, H; Nishikimi, T; Ono, H1

Other Studies

1 other study(ies) available for nadp and Hypertension, Malignant

ArticleYear
Long-term administration of rho-kinase inhibitor ameliorates renal damage in malignant hypertensive rats.
    Hypertension (Dallas, Tex. : 1979), 2006, Volume: 47, Issue:6

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Desoxycorticosterone; Dinoprost; Dose-Response Relationship, Drug; Drug Administration Schedule; Ectodysplasins; Gene Expression; Hypertension, Malignant; Immunohistochemistry; Intracellular Signaling Peptides and Proteins; Kidney; Kidney Cortex; Membrane Proteins; NADP; Nitric Oxide Synthase Type III; Protein Isoforms; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Rats; Rats, Inbred SHR; Rats, Inbred WKY; rho-Associated Kinases; Tumor Necrosis Factors

2006